
Eir Partners has announced the final close of its third fund, Eir Partners III, with total commitments of $1 billion, significantly exceeding its $800 million target. Raised in just three months and closed on January 8, 2026, the fund marks a doubling in size compared to its predecessor and reflects strong investor confidence in the firm’s healthcare-focused investment strategy.
The fund attracted a diverse group of institutional investors, including endowments, pension funds, insurance companies, and family offices, with strong support from existing limited partners. Eir continues to emphasize alignment with investors through meaningful GP commitments, reinforcing its long-term partnership approach.
Eir focuses on investments in health tech and tech-enabled services, targeting companies across payer, provider, employer, and pharma technology segments. The firm leverages its operational expertise and industry relationships to build and scale differentiated platforms in the healthcare ecosystem.
Since its founding in 2015, Eir has completed more than 50 transactions across 14 platform investments and raised approximately $1.8 billion in total capital. With Fund III, the firm is well-positioned to continue executing its strategy of supporting mid-stage growth companies and developing next-generation healthcare leaders.
About Eir Partners Capital
Eir Partners Capital is a Miami-based private equity firm specializing in healthcare technology and tech-enabled services. The firm partners with entrepreneurs and management teams to build scalable, high-growth platforms across the healthcare sector. Eir combines deep industry expertise with a hands-on investment approach to drive long-term value creation.